According to studies conducted by Sun et al. on the human hepatocellular carcinoma cell line HepG2, it is suggested that using 2,4-dichlorophenoxyacetic acid interferes with glucose metabolism in the liver by activating PPARβ [174]. This evidence concerns the gene PPARD and hepatocellular carcinoma.